Alpelisib Completed Phase 1 Trials for Pre-menopausal Breast Cancer / PI3K Pathway Inhibition Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02058381A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer